Top News

FEATURED

Future of the Biomedical Research Workface

As our aging workforce expands, a decreasing number of young investigators are applying for National Institute of Health (NIH) R01-equivalent grants.

Basal Cell Carcinoma: "Cell of Origin"

Invasive basal cell carcinoma arises only from epidermal stem cells, according to a study published in Nature.

PD-1, Checkpoint Inhibitors May Benefit SCLC

Antibodies such as nivolumab and pembrolizumab that target the programmed cell death protein-1 (PD-1) may be promising for patients with small cell lung cancer (SCLC).

New Video Series: High-Risk Hodgkin Lymphoma

Patrick J. Stiff, MD of the Cardinal Bernardin Cancer Center in Maywood, Illinois

Statistical Significance, Uncertainty, and KEYNOTE-010

Readers should look for "anything that adds uncertainty to the analysis, including uncertainty in the measurements, differences in dropout rates among arms, missing data, and how they were handled in the analysis."

Prognostic Signatures Guide Adjuvant Chemo

Gene expression prognostic signatures continue to evolve to provide greater accuracy for both short- and long-term risk of recurrence.

CML: Improved Life Expectancy in Patients

Improvements in treatment have increased the life expectancy of patients with chronic myeloid leukemia (CML).

Telephone Interviews to Deliver Genetic Counseling

Telephone interviews to deliver genetic counseling may be non-inferior to in-person counseling.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

The Future of the Biomedical Research Workforce in the United States

The Future of the Biomedical Research Workforce in the United States

As our aging workforce expands, a decreasing number of young investigators are applying for National Institute of Health (NIH) R01-equivalent grants.

Researchers Identify the "Cell of Origin" in Basal Cell Carcinoma

Researchers Identify the "Cell of Origin" in Basal Cell Carcinoma

Invasive basal cell carcinoma arises only from epidermal stem cells, according to a study published in Nature.

Feature Articles

PD-1 and Checkpoint Inhibitors May Benefit Some Patients With SCLC

PD-1 and Checkpoint Inhibitors May Benefit Some Patients With SCLC

Antibodies such as nivolumab and pembrolizumab that target the programmed cell death protein-1 (PD-1) may be promising for patients with small cell lung cancer (SCLC).

Gene-expression Prognostic Signatures Guide Adjuvant Chemotherapy of Early-stage Breast Cancer

Gene-expression Prognostic Signatures Guide Adjuvant Chemotherapy of Early-stage Breast Cancer

Gene expression prognostic signatures continue to evolve to provide greater accuracy for both short- and long-term risk of recurrence.

Life Expectancy of Patients With CML Greatly Improved, but at What Cost?

Life Expectancy of Patients With CML Greatly Improved, but at What Cost?

Improvements in treatment have increased the life expectancy of patients with chronic myeloid leukemia (CML).

HIPAA: Reducing Liability by Managing Business Associates

HIPAA: Reducing Liability by Managing Business Associates

Now that vendors are accountable under HIPAA, you could face increased liability if these business associates are responsible for patient privacy breaches.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters